Lce1g inhibitors are a specialized group of chemical compounds designed to selectively interact with the Lce1g protein, an integral member of the Late Cornified Envelope (Lce) protein family. This family plays a significant role in skin biology, particularly in the formation of the cornified envelope, an essential component of the skin's outermost layer. The Lce1g protein, like its counterparts in the Lce family, is characterized by specific expression patterns in the skin, particularly in the epidermal layers. Inhibitors targeting Lce1g are the result of intricate molecular engineering processes that ensure specific and effective interaction with this protein. The development and study of Lce1g inhibitors focus on understanding the protein's unique molecular structure and its role in cellular processes.
The creation of Lce1g inhibitors involves sophisticated techniques in both medicinal chemistry and molecular biology. A deep understanding of the Lce1g protein's molecular structure is essential for designing effective inhibitors. The interaction between these inhibitors and the Lce1g protein is a crucial area of study, as it determines the efficacy and specificity of the inhibitor. This interaction typically involves the formation of a complex in which the inhibitor binds to particular sites on the protein, a process that requires precise alignment of molecular structures. This binding is often facilitated by hydrogen bonds and other types of molecular interactions. Designing Lce1g inhibitors also involves considerations of the compound's stability, solubility, and its capability to reach the target site within biological systems. This process involves striking a balance between hydrophobic and hydrophilic properties and takes into account the overall molecular size and shape of the compound. The intricate process of designing Lce1g inhibitors highlights the complexity and precision required to target specific proteins effectively, showcasing the advanced state of current biochemical and pharmacological research techniques.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
This compound is an inhibitor of G9a histone methyltransferase, which could lead to altered chromatin structure and transcriptional repression of certain genes. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
UNC0638 is a potent G9a and GLP histone methyltransferase inhibitor potentially decreasing expression of genes regulated by methylation. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646 is a selective p300/CBP histone acetyltransferase inhibitor, potentially affecting gene transcription by altering histone acetylation. | ||||||
I-CBP112 | 1640282-31-0 | sc-507494 | 25 mg | $400.00 | ||
This compound serves as an inhibitor of CBP/p300, which could downregulate genes under control of these acetyltransferases. | ||||||
Chaetocin | 28097-03-2 | sc-200893 | 200 µg | $126.00 | 5 | |
Chaetocin is a potent inhibitor of another histone methyltransferase, SUV39H1, which could modulate gene expression globally. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
It targets NF-kB, a transcription factor that regulates many genes, potentially leading to downregulation of some gene expression. | ||||||
Sinefungin | 58944-73-3 | sc-203263 sc-203263B sc-203263C sc-203263A | 1 mg 100 mg 1 g 10 mg | $271.00 $5202.00 $40368.00 $704.00 | 4 | |
A nucleoside antibiotic that functions as an inhibitor of S-adenosyl-L-methionine-dependent methyltransferase, which could affect methylation status and gene expression. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A benzamide histone deacetylase inhibitor that can modulate gene expression through changes in chromatin structure. | ||||||
Scriptaid | 287383-59-9 | sc-202807 sc-202807A | 1 mg 5 mg | $64.00 $183.00 | 11 | |
It inhibits histone deacetylase, leading to hyperacetylation of histones and potentially affecting gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor that can lead to increased histone acetylation and possible changes in gene expression. | ||||||